UBS O'Connor’s PTC Therapeutics PTCT Stock Holding History

UBS O'Connor’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14,548	Closed	-$711K	–	410
2025 Q2	$711K	Sell	14,548 -8,805	-38%	-$418K	0.02%	251
2025 Q1	$1.19M	Sell	23,353 -23,541	-50%	-$1.17M	0.03%	170
2024 Q4	$2.12M	Buy	46,894 +15,459	+49%	+$662K	0.05%	150
2024 Q3	$1.17M	Sell	31,435 -1,565	-5%	-$52.4K	0.03%	260
2024 Q2	$1.01M	Buy	33,000 +18,000	+120%	+$583K	0.03%	294
2024 Q1	$436K	Sell	15,000 -21,052	-58%	-$590K	0.01%	341
2023 Q4	$994K	Sell	36,052 -6,549	-15%	-$150K	0.03%	271
2023 Q3	$955K	Sell	42,601 -2,500	-6%	-$93K	0.02%	338
2023 Q2	$1.83M	Sell	45,101 -9,662	-18%	-$473K	0.04%	315
2023 Q1	$2.65M	Buy	+54,763	New	+$2.5M	0.06%	227
2015 Q4	–	Sell	-20,000	Closed	-$534K	–	508
2015 Q3	$534K	Buy	+20,000	New	+$855K	0.01%	409

Other funds holding PTCT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Toronto Dominion Bank

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return